Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial | Zendy

J. Zhao | Zendy; Isabelle Tostivint | Zendy; Lingdong Xu | Zendy; Jihan Huang | Zendy; Laëtitia Gambotti | Zendy; JeanJacques Boffa | Zendy; Min Yang | Zendy; Ling Wang | Zendy; Zhuxing Sun | Zendy; Xiaolan Chen | Zendy; Amélie Liou-Schischmanoff | Zendy; A Baumelou | Zendy; Teng Ma | Zendy; Guoyuan Lu | Zendy; Ling Li | Zendy; Chen Dai | Zendy; Laurence Piéroni | Zendy; Bingkaï Liu | Zendy; Qin Xiao | Zendy; Weiming He | Zendy; Yuejuan Wang | Zendy; Harvest F. Gu | Zendy; Wei Sun | Zendy

Open Access

Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial

Author(s) -

J. Zhao,

Isabelle Tostivint,

Lingdong Xu,

Jihan Huang,

Laëtitia Gambotti,

JeanJacques Boffa,

Min Yang,

Ling Wang,

Zhuxing Sun,

Xiaolan Chen,

Amélie Liou-Schischmanoff,

A Baumelou,

Teng Ma,

Guoyuan Lu,

Ling Li,

Chen Dai,

Laurence Piéroni,

Bingkaï Liu,

Qin Xiao,

Weiming He,

Yuejuan Wang,

Harvest F. Gu,

Wei Sun

Publication year - 2022

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc22-0607

Subject(s) - medicine , albuminuria , irbesartan , diabetes mellitus , type 2 diabetes , clinical trial , randomized controlled trial , kidney disease , disease , diabetic nephropathy , double blind , urology , endocrinology , blood pressure , pathology , alternative medicine , placebo

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research